The DOI matches its Crossref record.
The Relationship of Intracellular Iron Chelation to the Inhibition and Regeneration of Human Ribonucleotide Reductase
Open accessAbstract
The depletion of cellular iron can lead to the inhibition of ribonucleotide reductase, preventing new DNA synthesis and hence inhibiting cell proliferation. Electron paramagnetic resonance (EPR) spectroscopy has been used to examine simultaneously for the first time the relationship between chelation of intracellular iron and the rate of removal and regeneration of the tyrosyl radical of ribonucleotide reductase within intact human leukemia K562 cells. The different physiochemical characteristics of relatively hydrophobic low molecular weight bidentate hydroxypyridinone chelators and the higher molecular weight hexadentate ferrioxamine have been exploited to elucidate these interactions further. The base-line concentration of EPR-detectable mononuclear nonheme iron complexes was 3.15 =/- 1.05 microM, rising on incubation with chelators more rapidly with hydroxypyridinones than with desferrioxamine. Hydroxypyridinones also removed the tyrosyl radical more rapidly, apparently as a consequence of depletion of the intracellular iron pools necessary to regenerate the active enzyme and compatible with their reportedly greater cell toxicity. The radical decay rate is consistent with previous models, suggesting that iron is spontaneously removed from mammalian ribonucleotide reductase. Upon removal of extracellular chelator the regeneration of the tyrosyl radical was significantly faster for hydroxypyridinones than for desferrioxamine, consistent with their differential effects on cell cycle synchronization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Iron(iii) selective molecular and supramolecular fluorescent probes
Sahoo, S. K., Sharma, D., Bera, R. K., Crisponi, G., & Callan, J. F. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35152h · Cited by 779
The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer
Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721
The role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411
Self-citationYuan, J., Lovejoy, D. B., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-03-0868 · Cited by 381
Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC
Wu, K.-J., Polack, A., & Dalla-Favera, R. (1999) · Science · doi:10.1126/science.283.5402.676 · Cited by 326
Le, N. T. V., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-05-1866 · Cited by 321
Role of metal dyshomeostasis in Alzheimer's disease
Bonda, D. J., Lee, H.-G., Blair, J. A., Zhu, X., Perry, G., & Smith, M. A. (2011) · Metallomics · doi:10.1039/c0mt00074d · Cited by 319
Design of iron chelators with therapeutic application
Liu, Z. D., & Hider, R. C. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00050-4 · Cited by 287
Self-citationRibonucleotide Reductase Inhibitors and Future Drug Design
Shao, J., Zhou, B., Chu, B., & Yen, Y. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723949 · Cited by 284
Design of clinically useful iron(III)‐selective chelators
Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266
Self-citationMa, Y., Luo, W., Quinn, P. J., Liu, Z., & Hider, R. C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049751s · Cited by 268
Self-citationCancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
Richardson, D. R., Kalinowski, D. S., Lau, S., Jansson, P. J., & Lovejoy, D. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.003 · Cited by 258
The Pathophysiology of Transfusional Iron Overload
Porter, J. B., & Garbowski, M. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.003 · Cited by 120
Self-citationJones, D. T., Trowbridge, I. S., & Harris, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3857 · Cited by 75
Intracellular Chelation of Iron by Bipyridyl Inhibits DNA Virus Replication
Romeo, A. M., Christen, L., Niles, E. G., & Kosman, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010806200 · Cited by 69
Curnow, A., Mcllroy, B., Postle-Hacon, M., Porter, J., MacRobert, A., & Bown, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.671 · Cited by 68
Self-citationIron chelation and multiple sclerosis
Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63
Hoke, E. M., Maylock, C. A., & Shacter, E. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.029 · Cited by 62
Mitchell, K. M., Dotson, A. L., Cool, K. M., Chakrabarty, A., Benedict, S. H., & LeVine, S. M. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507078916 · Cited by 51
Comparative Radical Scavenging Ability of Bidentate Iron(III) Chelators
Kayyali, R., Pannala, A. S., Khodr, H., & Hider, R. C. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00602-3 · Cited by 46
Self-citationLarson, J. A., Higashi, D. L., Stojiljkovic, I., & So, M. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1461-1467.2002 · Cited by 46
Therapeutic Potential of Iron Chelators in Cancer Therapy
Richardson, D. R. (2002) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0593-8_12 · Cited by 40
The Treatment of Malaria with Iron Chelators
Hider, R. C., & Liu, Z. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06162.x · Cited by 26
Self-citation
Metadata
- Authors
- Cooper, C. E., Lynagh, G. R., Hoyes, K. P., Hider, R. C., Cammack, R., & Porter, J. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 271
- Issue
- 34
- Pages
- 20291-20299
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2058409066
- Cited by
- 176
- References
- 0
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.